Literature DB >> 16695662

THE PHOSPHORUS TURNOVER OF CARCINOMA OF THE HUMAN STOMACH AS MEASURED WITH RADIOACTIVE PHOSPHORUS.

J Schulman1, M Falkenheim, S J Gray.   

Abstract

Entities:  

Keywords:  PHOSPHORUS AND PHOSPHORUS COMPOUNDS/metabolism; STOMACH/cancer

Mesh：

Substances：

Year:  1949        PMID： 16695662      PMCID： PMC439577          DOI： 10.1172/JCI102055

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.

Authors:  Philip G Penketh; Richard A Finch; Rachel Sauro; Raymond P Baumann; Elena S Ratner; Krishnamurthy Shyam
Journal:  Chem Biol Drug Des       Date:  2017-07-17       Impact factor: 2.817

2.  Macroautoradiography with radiophosphorus in cancer of the stomach.

Authors:  O Gregor; O Andrýsek; B Bednár; L Haník; O Vanecková; L Sístek
Journal:  Gut       Date:  1965-06       Impact factor: 23.059

3.  The uptake of labelled phosphorous by cancer of the cervix; preliminary report.

Authors:  S H STURGIS; E DE MUYLDER; J V MEIGS
Journal:  Ann Surg       Date:  1951-03       Impact factor: 12.969

4.  Biological hazards in toxicity of radioactive isotopes.

Authors:  A M BRUES
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

5.  The clinical value of radioactive phosphorus (32P) in the diagnosis of esophageal cancer.

Authors:  R S Nelson; F L Lanza
Journal:  Am J Dig Dis       Date:  1969-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.